» Articles » PMID: 35326580

Hemodynamic Imaging in Cerebral Diffuse Glioma-Part A: Concept, Differential Diagnosis and Tumor Grading

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Mar 25
PMID 35326580
Authors
Affiliations
Soon will be listed here.
Abstract

Diffuse gliomas are the most common primary malignant intracranial neoplasms. Aside from the challenges pertaining to their treatment-glioblastomas, in particular, have a dismal prognosis and are currently incurable-their pre-operative assessment using standard neuroimaging has several drawbacks, including broad differentials diagnosis, imprecise characterization of tumor subtype and definition of its infiltration in the surrounding brain parenchyma for accurate resection planning. As the pathophysiological alterations of tumor tissue are tightly linked to an aberrant vascularization, advanced hemodynamic imaging, in addition to other innovative approaches, has attracted considerable interest as a means to improve diffuse glioma characterization. In the present part A of our two-review series, the fundamental concepts, techniques and parameters of hemodynamic imaging are discussed in conjunction with their potential role in the differential diagnosis and grading of diffuse gliomas. In particular, recent evidence on dynamic susceptibility contrast, dynamic contrast-enhanced and arterial spin labeling magnetic resonance imaging are reviewed together with perfusion-computed tomography. While these techniques have provided encouraging results in terms of their sensitivity and specificity, the limitations deriving from a lack of standardized acquisition and processing have prevented their widespread clinical adoption, with current efforts aimed at overcoming the existing barriers.

Citing Articles

Cerebrovascular Reactivity Mapping in Brain Tumors Based on a Breath-Hold Task Using Arterial Spin Labeling.

Calvo-Imirizaldu M, Solis-Barquero S, Aramendia-Vidaurreta V, Garcia de Eulate R, Dominguez P, Vidorreta M NMR Biomed. 2025; 38(3):e5317.

PMID: 39844376 PMC: 11754703. DOI: 10.1002/nbm.5317.


Multiparametric simultaneous hybrid F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (F-FDG PET/MRI) incorporating intratumoral and peritumoral regions for grading of glioma.

Liu P, Zeng Y, Qu H, Zheng W, Zhou T, Hang L Quant Imaging Med Surg. 2024; 14(8):5665-5681.

PMID: 39144048 PMC: 11320556. DOI: 10.21037/qims-24-280.


Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma.

Heidari M, Shokrani P J Med Signals Sens. 2024; 14:7.

PMID: 38993200 PMC: 11111132. DOI: 10.4103/jmss.jmss_30_22.


Review of tracer kinetic models in evaluation of gliomas using dynamic contrast-enhanced imaging.

Zhou J, Hou Z, Tian C, Zhu Z, Ye M, Chen S Front Oncol. 2024; 14:1380793.

PMID: 38947892 PMC: 11211364. DOI: 10.3389/fonc.2024.1380793.


Transient deoxyhemoglobin formation as a contrast for perfusion MRI studies in patients with brain tumors: a feasibility study.

Stumpo V, Sayin E, Bellomo J, Sobczyk O, van Niftrik C, Sebok M Front Physiol. 2024; 15:1238533.

PMID: 38725571 PMC: 11079274. DOI: 10.3389/fphys.2024.1238533.


References
1.
Calamante F, Thomas D, Pell G, Wiersma J, Turner R . Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab. 1999; 19(7):701-35. DOI: 10.1097/00004647-199907000-00001. View

2.
Bulakbasi N, Kocaoglu M, Farzaliyev A, Tayfun C, Ucoz T, Somuncu I . Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol. 2005; 26(9):2187-99. PMC: 7976133. View

3.
Mutsaerts H, Petr J, Groot P, Vandemaele P, Ingala S, Robertson A . ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 2020; 219:117031. DOI: 10.1016/j.neuroimage.2020.117031. View

4.
Zikou A, Sioka C, Alexiou G, Fotopoulos A, Voulgaris S, Argyropoulou M . Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas. Contrast Media Mol Imaging. 2019; 2018:6828396. PMC: 6305027. DOI: 10.1155/2018/6828396. View

5.
Miles K . Perfusion imaging with computed tomography: brain and beyond. Eur Radiol. 2008; 16 Suppl 7:M37-43. DOI: 10.1007/s10406-006-0194-1. View